NR1H4 ameliorates Parkinson’s disease via inhibiting astrocyte activation and neuroinflammation in a CEBPβ/NF-κB dependent manner

Jingwen Li(University of Arkansas at Fayetteville), Nian Xiong(Wuhan Union Hospital), Shurui Zhang(Union Hospital), Danfang Yu(Wuhan Red Cross Hospital), Guiying Kuang(Wuhan Red Cross Hospital), Qinwei Yu(Wuhan Red Cross Hospital), Xinyu Hu(Sun Yat-sen University), Long Liu(Capital Medical University), Tao Wang(Heilongjiang University of Chinese Medicine), Jinsha Huang(Huazhong University of Science and Technology), Yun Xia(Nanyang Technological University), Hanshu Liu(Union Hospital)
International Immunopharmacology
September 5, 2024
Cited by 13


Related Papers